[1]
Rakhi, S.A. et al. 2021. An in silico evaluation of CDK Inhibitors targeting BCL2, TS and mTOR. Asian Journal of Medical and Biological Research. 7, 2 (Jun. 2021), 126–131. DOI:https://doi.org/10.3329/ajmbr.v7i2.54991.